The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis
Open accessAbstract
Purpose of review: Optical coherence tomography (OCT) is a noninvasive in-vivo imaging tool that enables the quantification of the various retinal layer thicknesses. Given the frequent involvement of the visual pathway in multiple sclerosis, OCT has become an important tool in clinical practice, research and clinical trials. In this review, the role of OCT as a means to investigate visual pathway damage in multiple sclerosis is discussed. Recent findings: Evidence from recent OCT studies suggests that the peripapillary retinal nerve fibre layer (pRNFL) appears to be an ideal marker of axonal integrity, whereas the macular ganglion cell and inner plexiform layer (GCIP) thickness enables early detection of neuronal degeneration in multiple sclerosis. The thickness of the macular inner nuclear layer (INL) has been suggested as a biomarker for inflammatory disease activity and treatment response in multiple sclerosis. OCT parameters may also be used as an outcome measure in clinical trials evaluating the neuroprotective or regenerative potential of new treatments. Summary: OCT provides insights into multiple sclerosis beyond the visual pathway. It is capable of quantifying the major pathological hallmarks of the disease, specifically inflammation and neuroaxonal degeneration. OCT, therefore, has the potential to become another mainstay in the monitoring of multiple sclerosis patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Gray matter atrophy in multiple sclerosis: A longitudinal study
Fisher, E., Lee, J., Nakamura, K., & Rudick, R. A. (2008) · Annals of Neurology · doi:10.1002/ana.21436 · Cited by 670
Reproducibility of Nerve Fiber Layer Thickness Measurements Using Optical Coherence Tomography
Schuman, J. S., Pedut-Kloizman, T., Hertzmark, E., Hee, M. R., Wilkins, J. R., Coker, J. G., Puliafito, C. A., Fujimoto, J. G., & Swanson, E. A. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30410-7 · Cited by 665
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034823 · Cited by 627
Self-citationToosy, A. T., Mason, D. F., & Miller, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70259-x · Cited by 617
Quantifying axonal loss after optic neuritis with optical coherence tomography
Costello, F., Coupland, S., Hodge, W., Lorello, G. R., Koroluk, J., Pan, Y. I., Freedman, M. S., Zackon, D. H., & Kardon, R. H. (2006) · Annals of Neurology · doi:10.1002/ana.20851 · Cited by 610
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
Petzold, A., de Boer, J. F., Schippling, S., Vermersch, P., Kardon, R., Green, A., Calabresi, P. A., & Polman, C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70168-x · Cited by 596
Self-citation
Cited by
Cavaliere-Ballesta, C., Viladés, E., Alonso-Rodríguez, C., Rodrigo, M. J., Pablo, L. E., Miguel, J. M., López-Guillén, E., Sánchez‐Morla, E. M., Boquete, L., & García‐Martín, E. (2019) · Sensors · doi:10.3390/s19235323 · Cited by 86
“All these characteristics have meant that OCT has revolutionized daily clinical practice in neuro-ophthalmology, because the technique makes it possible to quantify, non-invasively, rapidly, objectively, reliably, and highly reproducibly [12], the major pathological hallmarks of the disease, specifically, inflammation…”
BackgroundGarcía‐Martín, E., Ortiz, M., Boquete, L., Sánchez‐Morla, E. M., Barea, R., Cavaliere-Ballesta, C., Viladés, E., Orduna, E., & Rodrigo, M. J. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104165 · Cited by 64
Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis
Oertel, F. C., Zimmermann, H. G., Brandt, A. U., & Paul, F. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1559051 · Cited by 57
“with neuroprotective or neuroregenerative drugs in ON and MS [205].”
BackgroundTavazzi, E., Jakimovski, D., Kühle, J., Hagemeier, J., Ozel, O., Ramanathan, M. K., Barro, C., Bergsland, N., Tomic, D., Kropshofer, H., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000737 · Cited by 41
Hernández, M., Ramon-Julvez, U., Viladés, E., Ciordía, B. C., Mayordomo, E., & García‐Martín, E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289495 · Cited by 27
“In particular, OCT has revealed that the retinal nerve fiber layer (RNFL) reflects the axonal integrity, while the ganglion cell layer (GCL) shows a progressive thinning since the early stages of MS [2, 14, 15].”
Background
Metadata
- Authors
- Wicki, C. A., Hanson, J. V. M., & Schippling, S.
- Affiliations
- ETH Zurich (CH)
- University of Zurich (CH)
- Neuroimmunology and Multiple Sclerosis Research, Department of Neurology
- Corresponding author
- Schippling, Sven
- Venue
- Current Opinion in Neurology
- Published
- 2018-10
- Volume
- 31
- Issue
- 5
- Pages
- 662-668
- ISSN
- 1350-7540 (ISSN-L)
- 1473-6551
- OpenAlex
- W2885679903
- Cited by
- 16
- References
- 80
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 1
- FWCI
- 0.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- other-oa
- Locations
- Current Opinion in Neurology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Biogen
- Teva Pharmaceutical Industries
- Myelin Repair Foundation
- Multiple Sclerosis Society
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- Schweizerische Multiple Sklerose Gesellschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- optical coherence tomography, multiple sclerosis, visual pathway, peripapillary retinal nerve fiber layer, axonal degeneration, neurodegeneration, biomarkers, disease activity, treatment response, neuroprotection, retinal imaging
- MeSH terms
- Humans, Multiple Sclerosis, Visual Pathways, Tomography, Optical Coherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis. https://app.cochat.ai/papers/10.1097/wco.0000000000000604
- The paper
- Wicki, C. A., Hanson, J. V. M., & Schippling, S. (2018). Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000604
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.